Abstract 1531: Development of PBMC derived tumor effector cells with potent pan-cancer cytolytic activity for autologous cellular immunotherapy
Authors: Frank Borriello, Joshua W. Keegan, James A. Lederer
Published: 2021-07-01
DOI:
10.1158/1538-7445.am2021-1531
Source:
Full article
Abstract
Abstract